The Scripps Research Institute

The Scripps Research Institute

The Scripps Research Institute

Overview
Date Founded

1990

Headquarters

10550 NORTH TORREY PINES ROAD LA, LA JOLLA, CA 92037 USA

Charitable Causes

Biological & Life Science Research
AIDS
Cancer Research
Neurology & Neuroscience
Education Research & Support
Alzheimer's Disease

Employees (Worldwide)

2,347

Industries

Biotechnology
Schools & Student Services

Company Description

The Scripps Research Institute (TSRI), one of the world's largest, private, non-profit research organizations, stands at the forefront of basic biomedical science, a vital segment of medical research that seeks to comprehend the most fundamental processes of life. Over the last decades, the institute has established a lengthy track record of major contributions to the betterment of health and the human condition. The institute — which is located on campuses in La Jolla, California, and Jupiter, Florida — has become internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune diseases, cardiovascular diseases, virology, and synthetic vaccine development. Particularly significant is the institute's study of the basic structure and design of biological molecules; in this arena TSRI is among a handful of the world's leading centers. The institute’s educational programs are also top-rate. The Kellogg School of Science and Technology is currently ranked among the best in the nation in its fields of biology and chemistry. Rather than isolating faculty members, students, and laboratories into separate and distinct disciplines, as is generally prescribed in universities, a cooperative, collaborative spirit is encouraged and embraced. While the level of scientific investigation is intense, the atmosphere is collegial, relaxed, and informal. Technicians, postdoctoral fellows, graduate students, and administrative support staff all are considered part of the team and are given the latitude and responsibility to accomplish their tasks so as to serve the best interests of science. The pursuit of scientific excellence is paramount and all efforts are directed toward that end. The bulk of the institute's funding is derived from the National Institutes of Health and other federal agencies. In today's environment of increasing competition for shrinking federal dollars, however, collaborative industrial partnerships with leading pharmaceutical companies provide additional funding in several areas key to the organization's research objectives. The Scripps Research Institute's adherence to the highest scientific standards, emphasis on a multidisciplinary approach to problem solving, participation in the perpetuation of knowledge through education, and continual pursuit of research excellence provide an unparalleled scientific environment.

Contact Data
Trying to get in touch with decision makers at The Scripps Research Institute? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Executive Director Science Communication

Chief Operating Officer

Dean of Faculty

Senior Director, Florida Operations

Skaggs Institute Director

Associate Dean of Graduate Studies, Scripps Florida

Executive Vice President, Florida Operations

Executive Vice President, Research & Academic Affairs

President Emeritus

Board of Directors

President & Chief Executive Officer at The Scripps Research Institute

Founder at ResMed, Inc.

Co-Founder at Alexandria Real Estate Equities, Inc.

Founder at The Yucaipa Companies LLC

Founder at Genentech, Inc.

Founder at Gephardt Group Government Affairs LLC

President, the Skaggs Institute for Research at The Scripps Research Institute

Executive Managing Director at Savills Studley, Inc.

Consulting Professor, Department of Chemistry at Stanford University

Distinguished Alumni
Kristina Burow is now Managing Director at ARCH Venture Corp.
Sheng Ding is now Co-Founder at Fate Therapeutics, Inc.
Paths to The Scripps Research Institute
Potential Connections via
Relationship Science
You
The Scripps Research Institute
Recent Transactions
Details Hidden

Epimmune, Inc. purchases Sequel Therapeutics, Inc. from The Scripps Research Institute

Advisors & Consultants
Auditor

Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.

Legal Advisor

DLA Piper provides legal services covering a broad range practice areas. It was created in 2005 by the merger of DLA, Piper Rudnick and Gray Cary, followed by growth in the CIS, Germany, Spain, Asia, the Middle East and US markets. Core practices include Litigation and Arbitration, Corporate and Finance, Real Estate and Real Estate Capital Markets, Regulatory and Government Affairs, Intellectual Property and Technology, Employment and Tax

Advisor

Chief Executive Officer at Sanky Communications, Inc.

Clients

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ.

Key Stats and Financials As of 2017
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$341M
Non-Profit Donations & Grants Received
Investments
Details Hidden

Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA.

Suppliers
Alexandria Real Estate Equities, Inc. Trusts & Funds | Pasadena, CA

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust, which engages in the ownership, operation, development, and redevelopment of life science and technology properties. It also provides a space for lease to the life science and technology industries which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Senior Housing Properties Trust Trusts & Funds | Newton, MA

Senior Housing Properties Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Triple Net Leased Senior Living Communities, Managed Senior Living Communities, MOBs and All Other. The Triple Net Leased Senior Living Communities segment offers short and long term residential care and other services for residents, which the company receive rents from the operators. The Managed Senior Living Communities segment includes short and long term residential care and other services for residents, which the company pays fees to the operator to manage the communities for its account. The MOBs segment refers to the tenants paying for rent. The All Other segment comprises operations, including properties that offer wellness, fitness and spa services to members. The company was founded on December 16, 1998 and is headquartered in Newton, MA.

Theralase Technologies, Inc. Medical Products & Equipment | Toronto, ON

Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Medical Laser Technology (MLT), and Anti-Cancer Technology (ACT) segments. The MLT segment focuses on the company's medical laser business, which researches, develops, commercializes and manufactures lasers used by the ACT division. The ACT segment research and development of photo dynamic compounds (PDCs) for the treatment of cancer. The company was founded by Roger J. Dumoulin-White on August 22, 1989 and is headquartered in Toronto, Canada.

Awards & Honors
Rank #184
2010
The Chronicle of Philanthropy - Philanthropy 400
Rank #216
2009
The Chronicle of Philanthropy - Philanthropy 400
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by The Scripps Research Institute. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of The Scripps Research Institute's profile does not indicate a business or promotional relationship of any kind between RelSci and The Scripps Research Institute.